<DOC>
	<DOC>NCT00726388</DOC>
	<brief_summary>This is an open-label, multiple-dose, safety study of DIC075V in patients with acute post-operative pain following abdominal or orthopedic surgery.</brief_summary>
	<brief_title>An Open-Label Safety Study Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain</brief_title>
	<detailed_description>This is an open-label, multiple-dose, multiple-day, single-arm safety study of repeat-doses of DIC075V in patients with acute post-operative pain following abdominal (i.e., non-laparoscopic abdominal surgeries) or orthopedic (e.g., hip or knee joint replacement) surgery. Eligible patients will receive DIC075V IV bolus q6 hours. Safety assessments will be collected at baseline (immediately prior to starting DIC075V therapy) and at study discharge or early termination.</detailed_description>
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>abdominal ( nonlaparoscopic abdominal surgeries) or orthopedic ( hip or knee joint replacement) surgery or other surgeries requiring multiple doses of parenterally administered NSAIDs over multiple days Expected stay &gt; 48 hrs bilirubin &gt; 2.5 mg/dl prothrombin time is &gt; 20% above the upper limit of normal serum creatinine is &gt; 1.9 mg/dl at screening. known allergy or hypersensitivity to diclofenac, other NSAIDs,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>safety</keyword>
	<keyword>diclofenac</keyword>
	<keyword>pain, postoperative</keyword>
</DOC>